Evidence map›Paper›PMID 30809104›Full record

ArticleClinical epidemiology2019

Randomized clinical trials with run-in periods: frequency, characteristics and reporting.

David Ruben Teindl Laursen, Asger Sand Paludan-Müller, Asbjørn Hróbjartsson

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Clinical epidemiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06342024 (Effects of Pistachio Consumption on Inflammatory Markers and Lean Body Mass in Recreationally Active Women and Men), which is not on this map. Cited by 34 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 4 pooled it
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06342024 naactive not recruitingnot on this mapstarted 2024, after this paper: background citation

Effects of Pistachio Consumption on Inflammatory Markers and Lean Body Mass in Recreationally Active Women and Men

TypeinterventionalSponsorVirginia Polytechnic Institute and State UniversityRan2024 to 2026Enrolled144ConditionsInflammatory ResponseArmsPistachio group
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 4 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Exercise and QUality Diet after Leukemia: A Randomized Weight Loss Trial among Adult Survivors of Childhood Leukemia in the Childhood Cancer Survivor Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Run-in periods and treatment outcomes in asthma trials: A narrative review.Contemporary clinical trials communications · 2024
    Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

David Ruben Teindl LaursenCentre for Evidence-Based Medicine Odense (CEBMO), Odense University Hospital, Odense, Denmark, David.Ruben.Teindl.Laursen@rsyd.dk.
Asger Sand Paludan-MüllerNordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark, David.Ruben.Teindl.Laursen@rsyd.dk.
Asbjørn HróbjartssonCentre for Evidence-Based Medicine Odense (CEBMO), Odense University Hospital, Odense, Denmark, David.Ruben.Teindl.Laursen@rsyd.dk.
University of Southern Denmark · DKRigshospitalet · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRun-in periods are occasionally used in randomized clinical trials to exclude patients after inclusion, but before randomization. In theory, run-in periods increase the probability of detecting a potential treatment effect, at the cost of possibly affecting external and internal validity. Adequate reporting of exclusions during the run-in period is a prerequisite for judging the risk of compromised validity. Our study aims were to assess the proportion of randomized clinical trials with run-in periods, to characterize such trials and the types of run-in periods and to assess their reporting. MATERIALS AND

methodsThis was an observational study of 470 PubMed-indexed randomized controlled trial publications from 2014. We compared trials with and without run-in periods, described the types of run-in periods and evaluated the completeness of their reporting by noting whether publications stated the number of excluded patients, reasons for exclusion and baseline characteristics of the excluded patients.

resultsTwenty-five trials reported a run-in period (5%). These were larger than other trials (median number of randomized patients 217 vs 90,

conclusionApproximately 1 in 20 trials used run-in periods, though much more frequently in industry trials. Reporting of the run-in period was often incomplete, precluding a meaningful assessment of the impact of the run-in period on the validity of trial results. We suggest that current trials with run-in periods are interpreted with caution and that updates of reporting guidelines for randomized trials address the issue.

Indexed as

enrichment designlead-in periodsresearch methodologyrun-in periodssingle-blind placebowashout periods

Identifiers

PMID30809104
PMCPMC6377048
OpenAlexW2912441125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.